Business

Correction: FDA-Multiple Sclerosis Drug story

By Washington Examiner
Published March 28, 2013 6:16pm ET
Add Washington Examiner on Google

WASHINGTON (AP) — In a story March 27 about a new multiple sclerosis drug, The Associated Press reported erroneously that Novartis’ drug Gilenya was launched in March 2011. The drug was launched in October 2010.

A corrected version of the story is below:

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.